Martin Wing-King has been part of the organization since 2008, initially with Pharmaterials, a company later acquired by Quotient Sciences in 2017. He has held various business development, project management leadership, and operations leadership roles with the company for over 17 years. 

Prior to joining the organization, Martin spent 8 years in custom API synthesis at Johnson Matthey Pharmaceutical Services.

Martin is one of our drug product subject matter experts. He holds a Bachelor of Science in Chemistry and Management from Brunel University London.